[1]
L. Remijn-Nelissen, W. Bakker, T. van Gelder, M. Tannemaat, and J. Verschuuren, “Symptomatic, pharmacological treatment of myasthenia gravis”., rrnmf, vol. 4, no. 3, Aug. 2023, doi: 10.17161/rrnmf.v4i3.19548.